The evidence leans constructive4 supporting, 0 against, 0 worth knowing
Supporting
trading 41% above its 200-day average
sitting at 92% of its 52-week range, with little overhead supply from trapped buyers
up 57% over twelve months
matches the market's strongest stocks, which has beaten the market by +0.37 points over 20 sessions across 48,607 past signals
Against
nothing the data supports either way
Worth knowing
nothing the data supports either way
What would change this read: a close below 696, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
How it has performed
price return over each window, measured against zero
What the scans say today
3 of 47 matched on 2026-08-21
CFF matches 3 of the 47 scans today, across 2 different kinds of evidence.
Order win filings were typically +0.20pt vs the market over the next 5 sessions (n=408) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362) · Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093)
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+7.8%
Versus 200-day average+41.1%
Below 52-week high-4.1%
Above 52-week low+94.8%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)42.6
Higher closes in last 51 of 5
Six-month return+85.90%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.